8-K - Vanda Pharmaceuticals Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Timothy Williams resigned as Senior Vice President, General Counsel and Secretary of Vanda Pharmaceuticals Inc., effective April 10, 2026, to pursue other endeavors.

Key Takeaways

1Timothy Williams resigned from his role as Senior Vice President, General Counsel and Secretary, a key legal and corporate governance position.

2Resignation is effective April 10, 2026, providing the company with a 12-day transition window following notification on March 29, 2026.

3The filing states Williams is departing 'to pursue other endeavors', with no disclosure of disagreement, misconduct, or involvement in financial reporting issues.

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) Resig

Management Change

Executive & Director Changes

Timothy Williams

Senior Vice President, General Counsel and Secretary

Resignation

Effective: 2026-04-10

To pursue other endeavors

Exhibits (1)

8-K